IL17A and psoriasis: Another study revealed that blockade of phosphatidylinositol 3-kinase (PI3K)δ or PI3Kγ ameliorated IMQ-induced psoriasis-like dermatitis, correlating with reduced IL-17 levels in the spleen serum and lesions (20).